Metabolic research peptides in this category include GLP-1, dual GLP-1/GIP and triple agonist compounds studied in published clinical and preclinical literature. All batches are COA-verified for purity.

Compounds such as semaglutide, tirzepatide and retatrutide are supplied for laboratory research into incretin receptor pharmacology and metabolic signalling. See our Research Hub comparison article for published trial context.

Investigational compounds — not approved for human therapeutic use. ≥99% HPLC purity target. Cold-chain aware packaging. Dispatched within 48 hours Australia-wide.